These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6288240)

  • 81. The treatment of uterine adenocarcinoma with medroxyprogesterone acetate.
    Horger EO; Williamson HO; Hester LL
    J S C Med Assoc; 1966 Jun; 62(6):217-23. PubMed ID: 5227728
    [No Abstract]   [Full Text] [Related]  

  • 82. [Apropos of 2 cases of true hypernephroma of the kidney].
    Bédard Y; Garneau R
    Laval Med; 1966 Oct; 37(8):866-72. PubMed ID: 5927806
    [No Abstract]   [Full Text] [Related]  

  • 83. Measurement of progesterone receptor in human renal cell carcinoma and normal renal tissue.
    McDonald MW; Diokno AC; Seski JC; Menon KM
    J Surg Oncol; 1983 Mar; 22(3):164-6. PubMed ID: 6834834
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Cancer of the urogenital tract: kidney. The basis for hormonal therapy.
    Bloom HJ
    JAMA; 1968 May; 204(7):605-6. PubMed ID: 5694486
    [No Abstract]   [Full Text] [Related]  

  • 85. The effect of 6-medroxyprogesterone acetate (Provera) on [131-I]tri-iodothyronine resin sponge uptake.
    Stolbach LL; Krant MJ; Mitchell ML
    J Endocrinol; 1969 Feb; 43(2):309-10. PubMed ID: 4180279
    [No Abstract]   [Full Text] [Related]  

  • 86. Advanced renal cell cancer.
    Kidney Int; 1981 Jul; 20(1):127-36. PubMed ID: 7300108
    [No Abstract]   [Full Text] [Related]  

  • 87. [Hormonal treatment of renal cell carcinoma].
    Satomi Y; Okamoto S
    Nihon Hinyokika Gakkai Zasshi; 1972 Nov; 63(11):939-50. PubMed ID: 4675185
    [No Abstract]   [Full Text] [Related]  

  • 88. [Azoospermia caused by cytostatic treatment].
    Immel L; Schirren C
    Z Haut Geschlechtskr; 1967 Nov; 42(21):643-6. PubMed ID: 5596904
    [No Abstract]   [Full Text] [Related]  

  • 89. [Therapy of malignant kidney neoplasms].
    Battke H
    Z Urol Nephrol; 1973 Feb; 66(2):147-50. PubMed ID: 4572681
    [No Abstract]   [Full Text] [Related]  

  • 90. Hormones in the treatment of metastatic renal cancer.
    Morales A; Kiruluta G; Lott S
    J Urol; 1975 Nov; 114(5):692-3. PubMed ID: 1185861
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Percutaneous arterial chemotherapeutic perfusion.
    Lang EK
    J La State Med Soc; 1970 Mar; 122(3):81-2. PubMed ID: 5433474
    [No Abstract]   [Full Text] [Related]  

  • 92. Renal cancer: is targeted therapy really empiric?
    Vaishampayan U
    Curr Clin Pharmacol; 2011 Aug; 6(3):143. PubMed ID: 21861802
    [No Abstract]   [Full Text] [Related]  

  • 93. Acute febrile reaction to streptozocin.
    Garnick MB; Ernst T; Martinez F
    N Engl J Med; 1984 Sep; 311(12):798. PubMed ID: 6236370
    [No Abstract]   [Full Text] [Related]  

  • 94. [Apparent influence of parenteral medroxyprogesterone acetate on the course and recurrence of psoriasis].
    Fossati S
    Minerva Ginecol; 1970 Oct; 22(20):993-5. PubMed ID: 5508775
    [No Abstract]   [Full Text] [Related]  

  • 95. Phase II study of medroxyprogesterone acetate with tamoxifen in advanced renal cell cancer.
    Fuks JZ; Aisner J; Van Echo DA; Wiernik PH
    Cancer Treat Rep; 1982 Sep; 66(9):1773-4. PubMed ID: 7116354
    [No Abstract]   [Full Text] [Related]  

  • 96. Advanced adenocarcinoma of the kidney: therapy with lomustine, vinblastine, hydroxyurea, and medroxyprogesterone acetate and regression analysis of factors relating to survival.
    Brubaker LH; Troner MB; Birch R
    Cancer Treat Rep; 1983; 67(7-8):741-2. PubMed ID: 6223695
    [No Abstract]   [Full Text] [Related]  

  • 97. High-dose medroxyprogesterone acetate in patients with renal adenocarcinoma and measurable lung metastases: a phase II study.
    Kjaer M; Frederiksen PL
    Cancer Treat Rep; 1986 Mar; 70(3):431-2. PubMed ID: 2937534
    [No Abstract]   [Full Text] [Related]  

  • 98. Tamoxifen: an overview of recent studies in the field of oncology.
    Patterson JS; Battersby LA
    Cancer Treat Rep; 1980; 64(6-7):775-8. PubMed ID: 7000349
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Yoshi 864 plus medroxyprogesterone acetate in adenocarcinoma of the kidney: A Southwest Oncology Group Study.
    Altman SJ; Stephens RL; Bonnet JD
    Cancer Treat Rep; 1982 Sep; 66(9):1781-2. PubMed ID: 6288240
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.